home / stock / nby / nby news


NBY News and Press, NovaBay Pharmaceuticals Inc. From 01/20/22

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...

NBY - NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces its commitment to donate 2.5 million KN95 protective mas...

NBY - NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Stockholders who have not voted on Proposal Two are strongly encouraged to vote their shares at the Special Meeting to reconvene on January 31, 2022 NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) (“NovaBay” or the “Company”), a...

NBY - NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms

Lubricating eye drops are the first choice for dry eye symptom relief, part of the global over-the-counter artificial tears market that is expected to reach $6.4 billion by 2028 New Avenova ® Lubricating Eye Drops along with Avenova Warm Eye Compress and Avenova Lid &...

NBY - NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference

Company to provide details on expansion strategy NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing scientifically formulated and clinically proven consumer products for the eyecare and skinc...

NBY - NovaBay Pharmaceuticals Holds Special Meeting of Stockholders

Proposals One, Three, and Four Pass; Meeting Adjourned with respect to Proposal Two Stockholders who have not voted on Proposal Two are strongly encouraged to vote their shares Meeting to reconvene on January 14, 2022 NovaBay ® Pharmaceuticals, Inc. ...

NBY - DERMAdoctor's Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces that DERMAdoctor’s Calm Cool + Corrected 1% Coll...

NBY - 3 Hot Penny Stocks To Buy In December According To Insiders

Penny Stocks Insiders Decided To Buy In December 2021 Penny stocks are a great way to make money in the stock market without waiting years for a return. Even though they’ve got more risk to account for, the way traders can leverage smaller sums of capital to reap hefty gains isn&...

NBY - Hot Penny Stocks To Buy? 7 To Watch As African Variant Shakes Markets

New African Virus Variant Puts These Penny Stocks In The Spotlight Today What’s going on in the stock market today? Earlier this week, we were heading into the holiday nearing record-high levels. Countless penny stocks were red hot, and retail traders were reaping the rewards...

NBY - NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fellow Stockholders: The purpose of this letter is to share some of my personal thoughts about NovaBay and...

NBY - NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q3 2021 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jody Cain – Investor Relations, LHA Justin Hall – Chief Executive Officer and General Counsel Andy Jones – Chief Financial Officer Audrey Kunin – ...

Previous 10 Next 10